SANUWAVE Health, Inc.
SNWV · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | -0.56 | 0.24 | 0.05 |
| FCF Yield | 0.17% | -0.06% | -0.56% | 0.26% |
| EV / EBITDA | 188.49 | 93.18 | 272.24 | -21.88 |
| Quality | ||||
| ROIC | 6.72% | 13.89% | 9.97% | 19.32% |
| Gross Margin | 77.94% | 78.30% | 79.04% | 77.87% |
| Cash Conversion Ratio | 0.10 | 0.94 | 0.27 | -0.06 |
| Growth | ||||
| Revenue 3-Year CAGR | 29.74% | 29.33% | 27.84% | 24.91% |
| Free Cash Flow Growth | 434.94% | 90.11% | -432.48% | -59.08% |
| Safety | ||||
| Net Debt / EBITDA | -1.71 | 6.03 | 15.59 | -1.58 |
| Interest Coverage | -0.85 | 1.00 | 0.53 | 0.96 |
| Efficiency | ||||
| Inventory Turnover | 0.37 | 0.37 | 0.36 | 0.55 |
| Cash Conversion Cycle | 136.86 | 111.96 | 97.28 | 45.60 |